Paul Holvoet
#166,278
Most Influential Person Now
Researcher
Paul Holvoet's AcademicInfluence.com Rankings
Paul Holvoetcomputer-science Degrees
Computer Science
#10002
World Rank
#10493
Historical Rank
Machine Learning
#4525
World Rank
#4576
Historical Rank
Artificial Intelligence
#4883
World Rank
#4947
Historical Rank
Database
#6953
World Rank
#7195
Historical Rank
Download Badge
Computer Science
Paul Holvoet's Degrees
- PhD Computer Science Stanford University
- Masters Artificial Intelligence University of California, Berkeley
- Bachelors Computer Engineering University of California, Berkeley
Similar Degrees You Can Earn
Why Is Paul Holvoet Influential?
(Suggest an Edit or Addition)Paul Holvoet's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease. (1998) (723)
- Obesity, regional body fat distribution, and the metabolic syndrome in older men and women. (2005) (624)
- Circulating Oxidized LDL Is a Useful Marker for Identifying Patients With Coronary Artery Disease (2001) (546)
- Oxidized LDL and HDL: antagonists in atherothrombosis (2001) (444)
- Deficient t-PA Release and Elevated PA Inhibitor Levels in Patients with Spontaneous or Recurrent Deep Venous Thrombosis (1987) (376)
- Biomechanical factors in atherosclerosis: mechanisms and clinical implications. (2014) (331)
- The metabolic syndrome, circulating oxidized LDL, and risk of myocardial infarction in well-functioning elderly people in the health, aging, and body composition cohort. (2004) (311)
- MicroRNA-containing microvesicles regulating inflammation in association with atherosclerotic disease. (2013) (281)
- Identifying circulating microRNAs as biomarkers of cardiovascular disease: a systematic review (2016) (266)
- Association between circulating oxidized low-density lipoprotein and incidence of the metabolic syndrome. (2008) (264)
- Assay of Human Tissue-Type Plasminogen Activator (t-PA) with an Enzyme-Linked Immunosorbent Assay (ELISA) Based on Three Murine Monoclonal Antibodies to t-PA (1985) (251)
- The vicious circle between oxidative stress and inflammation in atherosclerosis (2009) (237)
- MicroRNAs regulating oxidative stress and inflammation in relation to obesity and atherosclerosis (2011) (224)
- Malondialdehyde-modified low density lipoproteins in patients with atherosclerotic disease. (1995) (221)
- Oxidized lipoproteins in atherosclerosis and thrombosis (1994) (208)
- Adenovirus-Mediated Gene Transfer of Human Platelet-Activating Factor–Acetylhydrolase Prevents Injury-Induced Neointima Formation and Reduces Spontaneous Atherosclerosis in Apolipoprotein E–Deficient Mice (2001) (199)
- Relations between metabolic syndrome, oxidative stress and inflammation and cardiovascular disease. (2008) (198)
- The Importance of Catch‐up Growth after Early Malnutrition for the Programming of Obesity in Male Rat (2006) (197)
- Metabolic syndrome and the risk of cardiovascular disease in older adults. (2006) (196)
- Oxidized low density lipoproteins in patients with transplant-associated coronary artery disease. (1998) (189)
- Correlation between Oxidized Low Density Lipoproteins and von Willebrand Factor in Chronic Renal Failure (1996) (187)
- Increased Low-Density Lipoprotein Oxidation and Impaired High-Density Lipoprotein Antioxidant Defense Are Associated With Increased Macrophage Homing and Atherosclerosis in Dyslipidemic Obese Mice: LCAT Gene Transfer Decreases Atherosclerosis (2003) (179)
- Domain Structure and Lipid Interaction in Human Apolipoproteins A-I and E, a General Model* (2003) (175)
- Human Paraoxonase-1 Overexpression Inhibits Atherosclerosis in a Mouse Model of Metabolic Syndrome (2006) (172)
- Association of High Coronary Heart Disease Risk Status With Circulating Oxidized LDL in the Well-Functioning Elderly: Findings From the Health, Aging, and Body Composition Study (2003) (169)
- Oxidative Stress and Insulin Resistance (2009) (162)
- Association between oxidized LDL, obesity and type 2 diabetes in a population‐based cohort, the Health, Aging and Body Composition Study (2009) (156)
- HDLassociated PAF‐AH reduces endothelial adhesiveness in apoE−/− mice (2000) (156)
- Apolipoprotein-mediated Plasma Membrane Microsolubilization (1999) (149)
- The relationship between oxidized LDL and other cardiovascular risk factors and subclinical CVD in different ethnic groups: the Multi-Ethnic Study of Atherosclerosis (MESA). (2007) (138)
- Oxidation of low density lipoproteins in the pathogenesis of atherosclerosis. (1998) (138)
- Weight Loss-Associated Induction of Peroxisome Proliferator-Activated Receptor-&agr; and Peroxisome Proliferator–Activated Receptor-&ggr; Correlate With Reduced Atherosclerosis and Improved Cardiovascular Function in Obese Insulin-Resistant Mice (2004) (131)
- Malondialdehyde-modified LDL as a marker of acute coronary syndromes. (1999) (128)
- Thrombosis and atherosclerosis (1997) (125)
- Defective Leptin/Leptin Receptor Signaling Improves Regulatory T Cell Immune Response and Protects Mice From Atherosclerosis (2007) (124)
- α-Helix Formation Is Required for High Affinity Binding of Human Apolipoprotein A-I to Lipids* (2004) (119)
- Mitochondrial Reactive Oxygen Species and Risk of Atherosclerosis (2012) (118)
- Decreased miR-181a expression in monocytes of obese patients is associated with the occurrence of metabolic syndrome and coronary artery disease. (2012) (116)
- Oxidized low density lipoprotein is a prognostic marker of transplant-associated coronary artery disease. (2000) (112)
- Fibrinolytic Response and Fibrin Fragment D-Dimer Levels in Patients with Deep Vein Thrombosis (1987) (104)
- Influence of exercise at lower and higher intensity on blood pressure and cardiovascular risk factors at older age (2009) (103)
- Thrombospondin-1 Deficiency Accelerates Atherosclerotic Plaque Maturation in ApoE−/− Mice (2008) (102)
- Extracellular Vesicles in Cardiovascular Theranostics (2017) (101)
- CREB activation induced by mitochondrial dysfunction triggers triglyceride accumulation in 3T3-L1 preadipocytes (2006) (96)
- LDL hypercholesterolemia is associated with accumulation of oxidized LDL, atherosclerotic plaque growth, and compensatory vessel enlargement in coronary arteries of miniature pigs. (1998) (96)
- Oxidized LDL and coronary heart disease (2004) (96)
- Effects of adenovirus-mediated human apo A-I gene transfer on neointima formation after endothelial denudation in apo E-deficient mice. (1997) (95)
- An Enzyme-Linked Immunosorbent Assay (ELISA) for the Measurement of Plasmin-α2-Antiplasmin Complex in Human Plasma - Application to the Detection of In Vivo Activation of the Fibrinolytic System (1986) (88)
- Decrease of miR-146b-5p in Monocytes during Obesity Is Associated with Loss of the Anti-Inflammatory but Not Insulin Signaling Action of Adiponectin (2012) (88)
- A monoclonal antibody specific for Lys-plasminogen. Application to the study of the activation pathways of plasminogen in vivo. (1985) (85)
- Arg123-Tyr166 Domain of Human ApoA-I Is Critical for HDL-Mediated Inhibition of Macrophage Homing and Early Atherosclerosis in Mice (2001) (85)
- Analytical performance and diagnostic accuracy of immunometric assays for the measurement of circulating oxidized LDL. (2006) (81)
- Oxidized LDL and the metabolic syndrome. (2008) (80)
- Interleukin-1 Receptor-Associated Kinase-3 Is a Key Inhibitor of Inflammation in Obesity and Metabolic Syndrome (2012) (79)
- Dyslipidaemia in type II diabetic mice does not aggravate contractile impairment but increases ventricular stiffness. (2008) (78)
- Plaque-associated endothelial dysfunction in apolipoprotein E-deficient mice on a regular diet. Effect of human apolipoprotein AI. (2003) (77)
- Exosomes: emerging roles in communication between blood cells and vascular tissues during atherosclerosis (2015) (76)
- Association between circulating oxidized low-density lipoprotein and incidence of the metabolic syndrome (2008) (74)
- Dietary cholesterol withdrawal reduces vascular inflammation and induces coronary plaque stabilization in miniature pigs. (2002) (73)
- Phospholipid binding and lecithin-cholesterol acyltransferase activation properties of apolipoprotein A-I mutants. (1995) (72)
- Stevioside inhibits atherosclerosis by improving insulin signaling and antioxidant defense in obese insulin-resistant mice (2010) (69)
- Hematopoietic Stem/Progenitor Cell Proliferation and Differentiation Is Differentially Regulated by High-Density and Low-Density Lipoproteins in Mice (2012) (69)
- Increased Levels of Low-Density Lipoprotein Oxidation in Patients with Familial Hypercholesterolemia and in End-Stage Renal Disease Patients on Hemodialysis (2003) (68)
- 2 The oxidation hypothesis of atherosclerosis (1997) (68)
- Adipose Tissue Expression of Gelatinases in Mouse Models of Obesity (2001) (66)
- Effect of overexpression of human apo A-I in C57BL/6 and C57BL/6 apo E-deficient mice on 2 lipoprotein-associated enzymes, platelet-activating factor acetylhydrolase and paraoxonase. Comparison of adenovirus-mediated human apo A-I gene transfer and human apo A-I transgenesis. (2000) (66)
- Prevention of fatty streak formation of 17beta-estradiol is not mediated by the production of nitric oxide in apolipoprotein E-deficient mice. (1997) (66)
- Biomechanical factors and macrophages in plaque stability. (2013) (64)
- Increased PAFAH and Oxidized Lipids Are Associated With Inflammation and Atherosclerosis in Hypercholesterolemic Pigs (2009) (62)
- A Comparative Metabolomics Approach Reveals Early Biomarkers for Metabolic Response to Acute Myocardial Infarction (2016) (62)
- Malondialdehyde-modified low density lipoproteins in patients with atherosclerotic disease (1995) (62)
- Single cell transcriptomics based-MacSpectrum reveals novel macrophage activation signatures in diseases. (2019) (62)
- Oxidative modification of low-density lipoproteins and the outcome of renal allografts at 1 1/2 years. (2001) (61)
- Endothelial dysfunction, oxidation of low-density lipoprotein, and cardiovascular disease. (1999) (61)
- Telomere length and its associations with oxidized-LDL, carotid artery distensibility and smoking. (2010) (60)
- Time course of thrombolysis induced by intravenous bolus or infusion of tissue plasminogen activator in a rabbit jugular vein thrombosis model. (1989) (58)
- Circular RNAs as Potential Theranostics in the Cardiovascular System (2018) (54)
- Characterization of functional domains in human tissue-type plasminogen activator with the use of monoclonal antibodies. (1986) (52)
- Characterization of a chimeric plasminogen activator consisting of a single-chain Fv fragment derived from a fibrin fragment D-dimer-specific antibody and a truncated single-chain urokinase. (1991) (50)
- Primary Structure and Gene Structure of Staphylokinase (1992) (50)
- Characterization of a recombinant single-chain molecule comprising the variable domains of a monoclonal antibody specific for human fibrin fragment D-dimer. (1991) (50)
- Paraoxonase 1 gene transfer lowers vascular oxidative stress and improves vasomotor function in apolipoprotein E‐deficient mice with pre‐existing atherosclerosis (2008) (49)
- Rosuvastatin restores superoxide dismutase expression and inhibits accumulation of oxidized LDL in the aortic arch of obese dyslipidemic mice (2007) (49)
- CD36 Inhibitors Reduce Postprandial Hypertriglyceridemia and Protect against Diabetic Dyslipidemia and Atherosclerosis (2012) (49)
- Oxidized Low-Density Lipoprotein Correlates Positively With Toll-Like Receptor 2 and Interferon Regulatory Factor-1 and Inversely With Superoxide Dismutase-1 Expression: Studies in Hypercholesterolemic Swine and THP-1 Cells (2006) (48)
- Effects of Enrichment of Fibroblasts with Unesterified Cholesterol on the Efflux of Cellular Lipids to Apolipoprotein A-I* (2002) (48)
- Rosuvastatin increases vascular endothelial PPARgamma expression and corrects blood pressure variability in obese dyslipidaemic mice. (2008) (48)
- Pioglitazone improves myocardial blood flow and glucose utilization in nondiabetic patients with combined hyperlipidemia: a randomized, double-blind, placebo-controlled study. (2007) (47)
- Sustained expression of human apolipoprotein A-I after adenoviral gene transfer in C57BL/6 mice: role of apolipoprotein A-I promoter, apolipoprotein A-I introns, and human apolipoprotein E enhancer. (2000) (46)
- Oxidized LDL and the metabolic syndrome. (2006) (45)
- MicroRNAs as early biomarkers in obesity and related metabolic and cardiovascular diseases. (2013) (45)
- Dietary antioxidants and forced expiratory volume in 1 s decline: the Health, Aging and Body Composition study (2011) (45)
- Gelatinolytic Activity in Atherosclerotic Plaques Is Highly Localized and Is Associated With Both Macrophages and Smooth Muscle Cells In Vivo (2007) (44)
- Pharmacokinetic and thrombolytic properties of chimeric plasminogen activators consisting of a single-chain Fv fragment of a fibrin-specific antibody fused to single-chain urokinase. (1993) (44)
- Rosiglitazone and fenofibrate exacerbate liver steatosis in a mouse model of obesity and hyperlipidemia. A transcriptomic and metabolomic study. (2014) (44)
- Beta-actin cannot be used as a control for gene expression in ovine interstitial cells derived from heart valves. (2004) (43)
- Relationship of lipoprotein-associated phospholipase A2 and oxidized low density lipoprotein in carotid atherosclerosis[S] (2009) (43)
- Hypercholesterolemia in Minipigs Impairs Left Ventricular Response to Stress: Association With Decreased Coronary Flow Reserve and Reduced Capillary Density (2002) (41)
- Lipoprotein peroxidation and mobility limitation: results from the Health, Aging, and Body Composition Study. (2005) (41)
- Association of Endothelial and Oxidative Stress with Metabolic Syndrome and Subclinical Atherosclerosis: Multi-Ethnic Study of Atherosclerosis (2011) (39)
- Stevia-derived compounds attenuate the toxic effects of ectopic lipid accumulation in the liver of obese mice: a transcriptomic and metabolomic study. (2015) (39)
- Oxidative modification of low-density lipoproteins in atherothrombosis. (1998) (38)
- Stress in Obesity and Associated Metabolic and Cardiovascular Disorders (2012) (37)
- Measurement of free, one-chain tissue-type plasminogen activator in human plasma with an enzyme-linked immunosorbent assay based on an active site-specific murine monoclonal antibody. (1987) (36)
- Thrombolytic Profiles of Clot‐Targeted Plasminogen Activators Parameters Determining Potency and Initial and Maximal Rates (1993) (36)
- Chlamydia pneumoniae induces neointima formation in coronary arteries of normal pigs. (2003) (35)
- Hypercholesterolemia impairs vascular remodelling after porcine coronary angioplasty. (2002) (34)
- Identification of the phospholipase A2 isoforms that contribute to arachidonic acid release in hypoxic endothelial cells: limits of phospholipase A2 inhibitors (2002) (34)
- beta-VLDL hypercholesterolemia relative to LDL hypercholesterolemia is associated with higher levels of oxidized lipoproteins and a more rapid progression of coronary atherosclerosis in rabbits. (1997) (33)
- Binding Properties of Monoclonal Antibodies against Human Fragment D-Dimer of Cross-Linked Fibrin to Human Plasma Clots in an In Vivo Model in Rabbits (1989) (33)
- PPAR Agonist-Induced Reduction of Mcp1 in Atherosclerotic Plaques of Obese, Insulin-Resistant Mice Depends on Adiponectin-Induced Irak3 Expression (2013) (32)
- Obesity-asthma association: is it explained by systemic oxidant stress? (2009) (32)
- Oxidized low‐density lipoprotein‐induced expression of ABCA1 in blood monocytes precedes coronary atherosclerosis and is associated with plaque complexity in hypercholesterolemic pigs (2007) (31)
- Examining the association between salivary cortisol levels and subclinical measures of atherosclerosis: The Multi-Ethnic Study of Atherosclerosis (2013) (31)
- Molecular and functional characterization of ovine cardiac valve-derived interstitial cells in primary isolates and cultures. (2003) (31)
- Differential associations of weight dynamics with coronary artery calcium versus common carotid artery intima-media thickness: The CARDIA Study. (2010) (29)
- Low MT‐CO1 in Monocytes and Microvesicles Is Associated With Outcome in Patients With Coronary Artery Disease (2016) (27)
- Peroxisome Proliferator-Activated Receptor-α,γ-Agonist Improves Insulin Sensitivity and Prevents Loss of Left Ventricular Function in Obese Dyslipidemic Mice (2006) (27)
- Role of the Arg123–Tyr166 Paired Helix of Apolipoprotein A-I in Lecithin:Cholesterol Acyltransferase Activation* (1997) (27)
- Stimulation with a monoclonal antibody (mAb4E4) of scavenger receptor-mediated uptake of chemically modified low density lipoproteins by THP-1-derived macrophages enhances foam cell generation. (1994) (27)
- A monoclonal antibody preventing binding of tissue-type plasminogen activator to fibrin: useful to monitor fibrinogen breakdown during t-PA infusion. (1986) (26)
- Thrombolytic and Pharmacokinetic Properties of a Recombinant Chimeric Plasminogen Activator Consisting of a Fibrin Fragment D-Dimer Specific Humanized Monoclonal Antibody and a Truncated Single-Chain Urokinase (1992) (26)
- Statins for calcific aortic valve stenosis: into oblivion after SALTIRE and SEAS? An extensive review from bench to bedside. (2010) (25)
- Gene therapy approaches for cardiovascular diseases. (2004) (24)
- Pioglitazone added to conventional lipid-lowering treatment in familial combined hyperlipidaemia improves parameters of metabolic control: relation to liver, muscle and regional body fat content. (2007) (24)
- S-nitrosothiols do not induce oxidative stress, contrary to other nitric oxide donors, in cultures of vascular endothelial or smooth muscle cells. (2001) (22)
- Effects of Deletion of the Carboxyl-terminal Domain of ApoA-I or of Its Substitution with Helices of ApoA-II on in Vitro and in Vivo Lipoprotein Association* (1996) (21)
- Low cytochrome oxidase 4I1 links mitochondrial dysfunction to obesity and type 2 diabetes in humans and mice (2015) (21)
- 213 Thrombus imaging with 123I-labeled Fab fragments of two fibrin fragment D-dimer specific antibodies in a rabbit model of venous thrombosis (1988) (20)
- Experimental Pulmonary Embolus in the Rat: A New in vivo Model to Test Thrombolytic Drugs (1988) (20)
- Smooth Muscle Cells Influence Monocyte Response to LDL as well as Their Adhesion and Transmigration in a Coculture Model of the Arterial Wall (2001) (19)
- Functional Role of Cardiovascular Exosomes in Myocardial Injury and Atherosclerosis. (2017) (19)
- Peroxisome proliferator-activated receptor-alpha,gamma-agonist improves insulin sensitivity and prevents loss of left ventricular function in obese dyslipidemic mice. (2006) (18)
- Substitution of the carboxyl-terminal domain of apo AI with apo AII sequences restores the potential of HDL to reduce the progression of atherosclerosis in apo E knockout mice. (1998) (16)
- Food‐restriction in obese dyslipidaemic diabetic mice partially restores basal contractility but not contractile reserve (2009) (15)
- Antineutrophil cytoplasmatic antibodies in patients with premature atherosclerosis: prevalence and association with risk factors (2002) (14)
- Identification of the phospholipase A(2) isoforms that contribute to arachidonic acid release in hypoxic endothelial cells: limits of phospholipase A(2) inhibitors. (2002) (14)
- PLASMA LEVELS OF FRAGMENT D-DIMER OF CROSSLINKED FIBRIN DURING THROMBOLYTIC THERAPY WITH RECOMBINANT TISSUE-TYPE PLASMINOGEN ACTIVATOR (1987) (13)
- Role of the carboxy-terminal domain of human apolipoprotein AI in high-density-lipoprotein metabolism--a study based on deletion and substitution variants in transgenic mice. (1997) (13)
- Bedside to bench: a look at experimental research with a clinical trial checklist (2014) (12)
- Relevance of Free tPA Assay Following Venous Occlusion in Patients with Venous Thromboembolic Disease (1988) (11)
- Myeloid Krüppel-like factor 2 is a critical regulator of metabolic inflammation (2020) (11)
- Restenosis and gene therapy (2001) (11)
- Angio-associated migratory cell protein and smooth muscle cell migration in development of restenosis and atherosclerosis. (2008) (10)
- Mir-1, miR-122, miR-132, and miR-133 Are Related to Subclinical Aortic Atherosclerosis Associated with Metabolic Syndrome (2021) (9)
- Biochemical characterization of single-chain chimeric plasminogen activators consisting of a single-chain Fv fragment of a fibrin-specific antibody and single-chain urokinase. (1992) (9)
- Direct quantitation of oxidized low-density-lipoprotein (oxldl) and assessment of its pole in atherothrombosis in end-stage renal-disease (esrd) patients (1995) (9)
- Low Cytochrome Oxidase 1 Links Mitochondrial Dysfunction to Atherosclerosis in Mice and Pigs (2017) (9)
- The Arg123-Tyr166 central domain of human ApoAI is critical for lecithin:cholesterol acyltransferase-induced hyperalphalipoproteinemia and HDL remodeling in transgenic mice. (2000) (9)
- A monoclonal antibody directed against the high-affinity lysine-binding site (LBS) of human plasminogen. Role of LBS in the regulation of fibrinolysis. (1986) (8)
- Expression and Characterization of Clustered Charge-to-Alanine Mutants of Low Mr Single-Chain Urokinase-Type Plasminogen Activator (1994) (7)
- Oxidative Stress and Inflammation in Cardiovascular Diseases and Cancer: Role of Non-coding RNAs (2022) (7)
- Adenovirus-mediated gene transfer of human PAF-AH prevents injury-induced neointima formation and reduces spontaneous atherosclerosis in apoE(-/-) mice (2001) (7)
- Peer review: (r)evolution needed (2017) (7)
- Role of oxidatively modified low density lipoproteins and anti-oxidants in atherothrombosis. (1999) (7)
- Obesity, the metabolic syndrome, and oxidized LDL. (2006) (6)
- The complex link between oxidised low-density lipoprotein and unstable angina (2007) (6)
- Pd endothelial dysfunction in apolipoprotein E-deficient mice on a regular diet. Effect of human apolipoprotein AI (2003) (5)
- Application of NIRS in mice: a study comparing the oxygenation of cerebral blood and main tissue oxygenation of mice and rat. (2006) (4)
- MONOCLONAL-ANTIBODIES DIRECTED AGAINST THE FIBRIN-BINDING SITE OR THE ACTIVE-SITE OF HUMAN TISSUE-TYPE PLASMINOGEN-ACTIVATOR (T-PA) (1985) (4)
- Lipid lowering and enhancement of fibrinolysis with niacin. (1995) (4)
- Increased levels of oxidized LDL in obese patients are normalised by treatment with atorvastatin (2000) (4)
- Effects of fibrin-targeting and clearance rate on the thrombolytic potency of chimeric plasminogen activators consisting of a single-chain Fv fragment derived from a fibrin-specific antibody and single-chain u-PA (scu-PA) (1992) (4)
- MicroRNAs regulating oxidative stress and inflammation in obesity and atherosclerosis (2012) (3)
- CHARACTERIZATION OF A SINGLE-CHAIN RECOMBINANT PLASMINOGEN-ACTIVATOR CONSISTING OF A FV FRAGMENT DERIVED FROM A D-DIMER SPECIFIC ANTIBODY AND LOW-MOLECULAR-WEIGHT SINGLE-CHAIN UROKINASE (RSCU-PA-32K) (1991) (3)
- THROMBUS IMAGING WITH MURINE MONOCLONAL ANTIBODIES AGAINST FIBRIN FRAGMENT D-DIMER IN A RABBIT JUGULAR VEIN THROMBOSIS MODEL (1987) (3)
- Human-like HDL -in vivo- reduces oxidative stress, Ca2+ transients, adhesion molecule expression and macrophage homing in apoE deficient mice (1999) (3)
- Expression and characterization of clustered charge-to-alanine mutants of low M(r) single-chain urokinase-type plasminogen activator. (1994) (3)
- Recullarisation of photo-oxidised pericardium using immature foreign body reaction in the construction of a tissue engineered heart valve (2004) (3)
- Circulating oxidized LDL is a useful marker for cardiovascular risk assessment (2001) (3)
- Intramural and intrapulmonary injection of chlamydia pneumoniae leads to coronary artery intimal proliferation in normal pigs (2000) (3)
- Natural sweetener stevioside inhibits atherosclerosis by increasing the antioxidant defence in obese, insulin-resistant mice (2009) (2)
- Quantitation and distribution of lipoprotein-associated phospholipase A(2) and oxidized low density lipoprotein in atherosclerotic lesions of carotid endarterectomy tissues (2006) (2)
- HDL-associated PAF-AH reduces endothelial adhesiveness in apoE 2 / 2 mice (2000) (2)
- Low MT-CO 1 in Monocytes and Microvesicles Is Associated With Outcome in Patients With Coronary Artery Disease (2016) (2)
- Abstract 757: Defective Leptin Signaling Improves Regulatory T Cell Immune Response And Protects Mice From Atherosclerosis (2007) (2)
- RNA-sequencing reveals that STRN, ZNF484 and WNK1 add to the value of mitochondrial MT-COI and COX10 as markers of unstable coronary artery disease (2019) (2)
- The metabolic syndrome is associated with elevated circulating oxidized LDL in the health, aging and body composition cohort (2002) (2)
- 3.P.206 Activation of human endothelial cells by minimally modified LDL and lysophosphatidylcholine: Investigation of the underlying signalling cascades (1997) (1)
- Abstract no.: 6 Endothelium‐dependent relaxation by purinergic receptors in the aorta of apolipoprotein E‐deficient mice (2005) (1)
- Promoter dependence of persistence of the effect of the human apo E enhancer on human apolipoprotein A-I expression after adenoviral gene transfer is partially explained by promoter attenuation (1999) (1)
- Is It Explained by Systemic Oxidant Stress (2009) (1)
- Dietary Antioxidants and FEV1in the Health Aging and Body Composition (Health ABC) Study. (2009) (1)
- Association between salivary cortisol levels and subclinical measures of atherosclerosis: the multi-ethnic study of atherosclerosis (2010) (1)
- Thrombolytic Profiles of Clot-Targeted Plasminogen Activators (2005) (1)
- Immunoscintigraphy of thrombi. (1991) (1)
- Effects of deletion or substitution of the carboxyterminal domain of human apolipoprotein A-I on high density lipoprotein metabolism in transgenic mice (1996) (1)
- Thrombolytic properties of a recombinant humanized antifibrin antibody/urokinase-type plasminogen activator chimera (1992) (1)
- Véronique Response and Protects Mice From Atherosclerosis Defective Leptin / Leptin Receptor Signaling Improves Regulatory T Cell Immune (2007) (1)
- Recovery of endothelial function and coronary plaque stabilisation after lipid lowering in LDL-hypercholesterolaemic pigs (2001) (1)
- The marker of cobalamin deficiency, plasma methylmalonic acid, may help identifying lysosomal iron trapping in patients. Its possible utility for heart failure (2021) (1)
- Low density lipoprotein cholesterol (LDL-C) (2014) (1)
- Non-coding RNAs Related to Atherosclerosis (2021) (1)
- Altered phosphorylation status of phospholamban and its contribution to the contractile dysfunction in mouse models of type II diabetes (2006) (1)
- 77 Role of the ARG123-TYR166 paired helix of APO A-I in lecithin:cholesterol acyltransferase activation (1997) (1)
- Abstract 3573: Higher Soluble Thrombomodulin is Associated with Risk of Coronary Artery Calcification: Longitudinal Analysis of the Multi-Ethnic Study of Atherosclerosis (MESA) (2007) (1)
- Platelets in Hematologic and Cardiovascular Disorders: Platelets and atherosclerosis (2002) (0)
- A Comparative Study On the Influence of Training Intensity On Blood Pressure and Cardiovascular Risk Factors At Older Age. (2009) (0)
- Adenoviral human apo A-I gene transfer in apo E-/- mice induces elevation in two lipoprotein-associated anti-inflammatory enzymes, PAF-acetylhydrolase and paraoxonase (1998) (0)
- Serum F2-isoprostanes and oxidized LDL are longitudinally associated with lower lung function: The cardia study (2008) (0)
- Mitochondrial Stress in Monocytes Is Reflected in Microvesicles and Associated with Metabolic and Coronary Artery Diseases (2016) (0)
- W15-P-008 PPARα,γ agonist-induced increase of insulin sensitivity, in the absence of triglyceride lowering, prevents loss of left ventricular function (2005) (0)
- The oxidation of LDL, the metabolic syndrome and atherosclerosis (2010) (0)
- Differences in development of cardiac contractile dysfunction in mice models of type II diabetes and the metabolic syndrome (2004) (0)
- The Arg123-Tyr166 central domain of human ApoAI is critical for HDL mediated inhibition of macrophage homing and early atherosclerosis in ApoE knockout mice independent of cholesterol efflux (2001) (0)
- Abstract 3304: Effects Of Pioglitazone On Myocardial Blood Flow And Glucose Utilization In Non-diabetic Patients With Familial Combined Hyperlipidemia (2007) (0)
- Hematopoietic Stem/progenitor Cells Contribute to Atherosclerotic Progression Via Integrin aM beta(2) (2013) (0)
- 3.P.165 Adhesion of monocytes in a coculture model of the arterial wall. Influence of LDL and LPC (1997) (0)
- The Impact of Non-coding RNA Networks on Disease Comorbidity: Cardiometabolic Diseases, Inflammatory Diseases, and Cancer (2021) (0)
- Communication Between Tumor-Adjacent Tissues and Tumors with Emphasis on Role of Inflammatory Cells (2021) (0)
- Oxidised LDL correlates with interferon regulatory factor 1: a link between oxidative stress and macrophage inflammatory response involving PPARgamma (2005) (0)
- Th-W52:1 Vessel-aging and mechanisms of atherothrombosis (2006) (0)
- Noncoding RNAs Controlling Oxidative Stress in Cancer (2023) (0)
- Recombinant human apo A-I adenoviruses lack hepatotropism after systemic injection in rabbits (1999) (0)
- Rosuvastatin restores NO-dependent endothelial function by increasing vascular PPARg and SOD1 expression (2007) (0)
- 145 Use of adenoviral vectors to increase reverse cholesterol transport (1997) (0)
- Impact of LDL-hypercholesterolemia and LDL lowering on atherosclerosis, endothelial reactivity and heart function in miniature pigs (2001) (0)
- Relationship Between Toll-Like Receptor Mediated Inflammation and Increased Oxidative Stress in Monocytes of Women with Elevated BMI Prior to Type-2 Diabetes and Cardiovascular Diseases (2009) (0)
- PPARalpha induction in adipose tissue correlates with increased insulin sensitivity and prevention of loss of left ventricular function. Effect of PPARalpha,gamma-agonist in obese dyslipidemic mice (2005) (0)
- Metabolic syndrome predicts adverse cardiovascular risk among the elderly (2005) (0)
- Enhancement of the thrombolytic potency of single chain urokinase-type plasminogen activator by conjugation with a monoclonal antibody against polymerized fibrin (1991) (0)
- Diagnostic value of plasma levels of oxidized LDL and of MDA-modified LDL in the assessment of stable angina and of acute coronary syndromes (1998) (0)
- Effect of the apo E enhancer on human apo A-I expression after adenoviral gene transfer with constructs containing the CMV promoter and human apo A-I promoter or containing only the human apo A-I promoter (1998) (0)
- Age-associated changes in left ventricular contractility and ventricular-vascular stiffness in apolipoprotein E-deficient mice (2007) (0)
- Persistence of human apo A-I expression after adenoviral gene transfer with apo A-I promoter driven constructs (1999) (0)
- A guide to atherosclerosis (2001) (0)
- Effect of anti-oxidative enzyme gene-transfer on endothelial cell function of apolipoprotein-E deficient mice (2006) (0)
- Induction of PPARs in the adipose tissue is a key mechanism for the weight loss-induced increase of insulin sensitivity, correction of dyslipidemia, inhibition of atherosclerosis, and improvement of cardiovascular function in obese insulin-resistant mice (2004) (0)
- Effect of the presence of introns, viral dose, and genetic background on long-term expression of human apo A-I after adenoviral gene transfer (1998) (0)
- The use of monoclonal antibodies in investigating coagulation and fibrinolysis (1985) (0)
- Detection and determination of disease stages coronary artery. (1999) (0)
- PPAR alpha,gamma agonist-induced increase of insulin sensitivity, in the absence of triglyceride lowering, prevents loss of left ventricular function (2005) (0)
- Non-coding RNAs at the Cross-Road of Cardiometabolic Diseases and Cancer (2021) (0)
- Obesity, the metabolic syndrome, and oxidized LDL. Authors' reply (2006) (0)
- Intramural injection of Chlamydia Pneumoniae leads to coronary artery intimal proliferation in normal pigs (2000) (0)
- Adenovirus-mediated gene transfer of human PAF-AH prevents injury-induced neointima formation and reduces spontaneous atherosclerosis in apoE-deficient mice (2001) (0)
- Oxidized Low-Density Lipoprotein and Malondialdehyde-Modified Low-Density Lipoprotein in Patients with Coronary Artery Disease (2003) (0)
- Biogenesis and Modes of Action of miRs and Circular and Long Non-coding RNAs (2021) (0)
- Differential effects of increasing hypercholesterolemia on smooth muscle cell function in plaque free aorta rings of apolipoprotein E-deficient mice (2008) (0)
- Atherosclerosis Atherosclerosis in Dyslipidemic Obese Mice : LCAT Gene Transfer Decreases Antioxidant Defense Are Associated With Increased Macrophage Homing and Increased Low-Density Lipoprotein Oxidation and Impaired High-Density Lipoprotein (2003) (0)
- Welcome to Cardiovascular Research in 2015. (2015) (0)
- Pharmacokinetic and thromboyltic properties of chimeric plasminogen activators consisting of a single-chain Fv fragment derived from a fibrin specific antibody (MA-15C5) and single-chain urokinase (scu-PA) (1992) (0)
- Abstract 12921: Hematopoietic Stem/progenitor Cells Contribute to Atherosclerotic Progression Via Integrin aMβ2 (2013) (0)
- Rosuvastatin increases insulin sensitivity and reduces atherosclerotic plaque volume and plaque macrophage and oxidized LDL content in obese dyslipidemic mice in the absence of cholesterol reduction (2006) (0)
- Abstract P369: Higher Diet quality is Prospectively Associated with Markers of Endothelial Dysfunction: The Coronary Artery Risk Development in Young Adults Study (2012) (0)
- Derives d'anticorps specifiques au thrombus (1991) (0)
- Atherogenic dyslipidemia in leptin-deficient diabetic mice models influences cardiac contractility (2005) (0)
- RELEVANCE OF FREE t-PA ASSAY FOLLOWING VENOUS OCCLUSION IN PATIENTS WITH VENOUS THROMBOEMBOLIC DISEASE (1987) (0)
- Non-coding RNAS Related to Type 2 Diabetes (2021) (0)
- Hypertension and sympathavagal imbalance are reversed by correction of insulinoresistance despite persistent dyslipidemia upon diet restriction in LDL receptor- and leptin-deficient mice (2004) (0)
- Fibrinolytic potency of chimeric plasminogen activators consisting of a single-chain Fv fragment from a fibrin specific antibody (MA-15C5) and of single-chain urokinase (scu-PA) (1992) (0)
- Mouse models of atherosclerosis (2004) (0)
- Detective leptin signaling improves regulatory T cell immune response and protects mice from atherosclerosis (2007) (0)
- Abstract 10237: Interleukin-1 Receptor-associated Kinase 3 (IRAK3) is a Potential Monocyte-related Link between Inflammation and Oxidative Stress in Obesity and Atherosclerosis (2010) (0)
- Non-coding RNAs Related to Lipid Metabolism and Non-alcoholic Fatty Liver Disease (2021) (0)
- 135: Kidney Function, Oxidized LDL and Cardiovascular Disease (CVD) (2007) (0)
- Effects of Homocysteine on the Cellular Responses of Murine Endothelial Cells Cultured in Vitro (2002) (0)
- Expression of beta-actin is not stable in ovine interstitial cells derived from heart valves (2003) (0)
- Platelets in Thrombotic and Non-thrombotic Disorders: Platelets and atherosclerosis (2002) (0)
- Th-W48:7 Porcine plasma PAF-acetylhydrolase: Physiology upon diet hyperlipidemia. A surrogate model of human atherosclerosis (2006) (0)
- Calcium handling in aortic smooth muscle cells of apolipoprotein E-deficient mice transfected with paraoxonase-1 (2005) (0)
- SUN-LB019 Myeloid Krüppel-like Factor 2 is a Critical Regulator of Metabolic Inflammation (2019) (0)
- Study of the role of Arg123-Tyr166 central domain of human apo A-I in lipoprotein association, LCAT induced HDL remodeling and atherosclerosis in transgenic mice (1999) (0)
- Insulin resistance and oxidative stress precede inflammation during the development of the metabolic syndrome and atherosclerosis in obese mice (2010) (0)
- LCAT gene transfer decreases atherosclerosis and oxidative stress in dyslipidemic obese mice (2003) (0)
- Poster Abstracts—Friday June 4, 2004PURINERGIC RECEPTORS AND ENDOTHELIUM-DEPENDENT RELAXATION IN THE AORTA OF APOLIPOPROTEIN E DEFICIENT MICE (2004) (0)
- Lipoprotein peroxidation and onset of mobility disability - Results from the health ABC study (2005) (0)
- Vessel-aging and mechanisms of atherothrombosis (2006) (0)
- Regulation of Non-coding RNAs in Cardiometabolic Tissues and Tumors (2021) (0)
- ESM August 2002 (2002) (0)
- Interaction between oxidative stress and inflammation in obesity (2011) (0)
- Weight reduction by food restriction improves cardiac contractility in a mouse model with the metabolic syndrome (2006) (0)
- [Development of new laboratory technics based on monoclonal antibodies in the diagnosis of deep venous thrombosis and in the evaluation of the systemic effects of thrombolytic treatment with tissue-type plasminogen activator]. (1986) (0)
- Atherosclerotic plaque volume correlates with arterial elastance in a mouse model of the metabolic syndrome (2006) (0)
- Non-coding RNAs Related to Cardiometabolic Diseases and Associated to Cancer (2021) (0)
- METHODS OF INVITRO AND INVIVO PLASMINOGEN ACTIVATION (1986) (0)
- Cross-sectional and prospective association between oxidized LDL, adiposity and type 2 diabetes (2007) (0)
- Human apolipoprotein (APO) AI protects endothelial function in atherosclerosis-prone apoE-deficient mice (2001) (0)
- 3.P.118 Oxidation of LDL, endothelial injury and coronary artery disease (1997) (0)
- Weight-loss in obese insulin-resistant mice induces changes in the adipose tissue gene expression profile that are associated with reversal of hypertriglyceridemia, increase of insulin-sensitivity and glucose tolerance, prevention of atherosclerosis, and improvement of cardiac function (2003) (0)
- infusion activator to fibrin: useful to monitor fibrinogen breakdown during t-PA A monoclonal antibody preventing binding of tissue-type plasminogen (2011) (0)
- Non-coding RNAs Related to Obesity (2021) (0)
- Non-coding RNAs in Cardiomyopathy and Heart Failure (2021) (0)
- Restricted dietary intake and weight-loss is associated with reversal of hypertriglyceridemia and prevention of atherosclerosis in obese dyslipidemic mice (2003) (0)
- Interleukin-1 receptor-associated kinase-3 plays a crucial role in rosiglitazone-mediated reduction of atherosclerotic plaque macrophages (2012) (0)
- Circulating oxidized LDL and the assessment of cardiovascular risk (2000) (0)
- Weight-loss changes PPAR expression, reduces atherosclerosis and improves cardiovascular function in obese insulin-resistant mice (2003) (0)
- Human apo A-I gene transfer inhibits restenosis in apo E deficient mice (1996) (0)
- Circulating oxidized LDL predicts future metabolic syndrome independent of lipid levels in the CARDIA study (2008) (0)
This paper list is powered by the following services:
Other Resources About Paul Holvoet
What Schools Are Affiliated With Paul Holvoet?
Paul Holvoet is affiliated with the following schools:
